Experienced in Carbamoyl Phosphate Synthetase 1 Deficiency

Dariusz M. Rokicki

Warsaw, MZ, PL 
Experienced in Carbamoyl Phosphate Synthetase 1 Deficiency
Warsaw, MZ, PL 
OverviewLocationsClinical Research

Overview

Dariusz Rokicki practices in Warsaw, Poland. Mr. Rokicki is rated as an Experienced expert by MediFind in the treatment of Carbamoyl Phosphate Synthetase 1 Deficiency. His top areas of expertise are Andersen Disease, Urea Cycle Disorders (UCD), Hyaline Fibromatosis Syndrome, Leigh Syndrome, and Liver Transplant.

His clinical research consists of co-authoring 70 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Carbamoyl Phosphate Synthetase 1 Deficiency.

Gender
Male

Locations

Warsaw, MZ, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospective, Open Label, Multicenter, Efficacy and Safety Study of Several Infusions of HepaStem in Urea Cycle Disorders Paediatric Patients
Prospective, Open Label, Multicenter, Efficacy and Safety Study of Several Infusions of HepaStem in Urea Cycle Disorders Paediatric Patients
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological
Study Phase: Phase 2
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C in Order to Characterise the Individual Patient Disease Profile and Historic Signo-symptomatology Progression Pattern
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C in Order to Characterise the Individual Patient Disease Profile and Historic Signo-symptomatology Progression Pattern
Enrollment Status: Completed
Publish Date: May 18, 2017
View 1 Less Clinical Trial

70 Total Publications

Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study.
Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study.
Journal: The British journal of ophthalmology
Published: April 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rokicki's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 63 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile